ACE and Hypertension: Participants who had a daily intake of ω-3 above the median (≥1.7 g/day) at admission had higher systolic blood pressure, higher levels of triglycerides and higher frequency of diabetes mellitus, hypertension, and coronary reperfusion therapy as well as the use of ACE inhibitors/ARBs than their counterparts.